Feed AFMDQ
Summary
36 / 100 · Bulios Score
Valuation 100Growth 0Profitability 20Quality 2Debt 68Stability 35
What speaks for it
- The price moves less than the market (beta 0.28).
What to watch
- Revenue fell by 34% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
2019202020212022202320262027
Diluted EPS (EUR)
2019202020212022202320262027
- Analyst estimate
Revenue fell by 34% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments 24.9M €
Debt 12.9M €
It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 5
- Sell 0
Today's price within the analysts' price targets
Today's price $0.0001 Average target $7.5
$0.0001 $10
The average target of $7.5 is 7,499,900% above today's price. 64% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Collaboration 94%
- Service 6.2%
By region
- USA 100%
- Germany 0.1%
Collaboration brings in 94% of revenue.
Segments in detail